Ceftazidime-avibactam with or without Aztreonam vs Polymyxin-based Combination Therapy for Carbapenem-resistant Enterobacteriaceae: A Retrospective Analysis.

Prayag, Parikshit S; Patwardhan, Sampada A; Panchakshari, Shweta; Sambasivam, Ramya; Dhupad, Surabhi; Soman, Rajeev N; Prayag, Amrita P

Prayag, Parikshit S; Patwardhan, Sampada A; Panchakshari, Shweta; Sambasivam, Ramya; Dhupad, Surabhi; Soman, Rajeev N; Prayag, Amrita P.

Afiliação

Prayag PS; Department of Infectious Diseases, Deenanath Mangeshkar Hospital, Pune, India.
Patwardhan SA; Department of Microbiology, Deenanath Mangeshkar Hospital, Pune, India.
Panchakshari S; Department of Infectious Diseases, Deenanath Mangeshkar Hospital, Pune, India.
Sambasivam R; Department of Infectious Diseases, Deenanath Mangeshkar Hospital, Pune, India.
Dhupad S; Department of Infectious Diseases, Deenanath Mangeshkar Hospital, Pune, India.
Soman RN; Department of Infectious Diseases, Jupiter Hospital, Pune, India.
Prayag AP; Department of In House Research, Deenanath Mangeshkar Hospital, Pune, India.

Indian J Crit Care Med ; 27(6): 444-450, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37378372

Palavras-chave

Carbapenem-resistant enterobacteriaceae; Carbapenems; Ceftazidime-avibactam; Gram-negative sepsis; Polymyxin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Indian J Crit Care Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google